Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)
CAPS Rating:
A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.
RSS Headlines
Fool UK
Recs
Despite strong growth in recent months, Gilead Sciences beat them to the punch on hepatitis C, upon which Idenix had hung its hopes. A rebound may take a while.